pharma news, views and analysis - pharmaphorum.com

Trending

in News
CSL accuses ex-exec, now at Pharming, of stealing trade secrets
October 16, 2019 Share
X
CSL accuses ex-exec, now at Pharming, of stealing trade secrets
https://pharmaphorum.com/news/csl-accuses-ex-exec-now-at-pharming-of-stealing-trade-secrets/
in News
UK’s Enterprise gets £5.7m backing for ‘universal’ cystic fibrosis drug
October 16, 2019 Share
X
UK’s Enterprise gets £5.7m backing for ‘universal’ cystic fibrosis drug
https://pharmaphorum.com/news/uks-enterprise-gets-5-7m-backing-for-universal-cystic-fibrosis-drug/

Latest News

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

Pfizer has reported new data with abrocitinib, a follow-up to its JAK inhibitor Xeljanz, which is facing increased

X

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

https://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/

Reata rockets on data for Nrf2 drug reacquired from AbbVie

Reata rockets on data for Nrf2 drug reacquired from AbbVie

Reata Pharma has reported positive clinical results with one of its Nrf2 activators for mitochondrial diseases, just days

X

Reata rockets on data for Nrf2 drug reacquired from AbbVie

https://pharmaphorum.com/news/reata-rockets-on-data-for-nrf2-drug-reacquired-from-abbvie/

Still too little progress on antibiotic resistance, says O’Neill report update

Still too little progress on antibiotic resistance, says O’Neill report update

The O’Neill report on antimicrobial resistance in 2016 generated headlines around the world warning that once-trivial infections may

X

Still too little progress on antibiotic resistance, says O’Neill report update

https://pharmaphorum.com/news/still-too-little-progress-on-antibiotic-resistance-says-oneill-report-update/

Views & Analysis

Q&A: Adaptimmune’s Elliot Norry on cell therapy

Q&A: Adaptimmune’s Elliot Norry on cell therapy

Dr Elliot Norry, interim chief medical officer at Adaptimmune, discusses the unique challenges of cell therapy, from manufacturing

X

Q&A: Adaptimmune’s Elliot Norry on cell therapy

https://pharmaphorum.com/views-analysis-market-access/qa-adaptimmune-elliot-norry-on-cell-therapy/

Bridging the gap between industry and charities: Enabling PPI in research

Bridging the gap between industry and charities: Enabling PPI in research

Public and patient involvement (PPI) in clinical research is the new normal, but bridging the gap between how

X

Bridging the gap between industry and charities: Enabling PPI in research

https://pharmaphorum.com/views-analysis-patients/bridging-the-gap-between-industry-and-charities-enabling-ppi-in-research/

A new breed of pharma manufacturing

A new breed of pharma manufacturing

Over the last few years the effect of Brexit’s political instability on our industry has been inescapable as

X

A new breed of pharma manufacturing

https://pharmaphorum.com/r-d/views-analysis-r-d/a-new-breed-of-pharma-manufacturing/

Debates & Insights

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

Overview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15

X

Navigating new frontiers: Ways to find space in the future RA market

https://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Partner Content

3rd Annual Dermatology Drug Development Summit

3rd Annual Dermatology Drug Development Summit

Industry meeting on advancing derm drug development

X

3rd Annual Dermatology Drug Development Summit

https://pharmaphorum.com/events/3rd-annual-dermatology-drug-development-summit/

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

X

Your Ultimate Guide To The Skin Microbiome

https://pharmaphorum.com/events/your-ultimate-guide-to-the-skin-microbiome/

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

Ophthalmic Drugs Conference Speaker Interview

X

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

https://pharmaphorum.com/partner-content/speaker-interview-with-iveena-released-for-3rd-ophthalmic-drugs-conference/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com